These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17073618)
1. Animal models used for the evaluation of antiretroviral therapies. Dias AS; Bester MJ; Britz RF; Apostolides Z Curr HIV Res; 2006 Oct; 4(4):431-46. PubMed ID: 17073618 [TBL] [Abstract][Full Text] [Related]
2. Optimizing animal models for HIV-associated CNS dysfunction and CNS reservoir research. Joseph J J Neurovirol; 2018 Apr; 24(2):137-140. PubMed ID: 29582355 [No Abstract] [Full Text] [Related]
3. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Gardner MB Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310 [TBL] [Abstract][Full Text] [Related]
4. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466 [TBL] [Abstract][Full Text] [Related]
5. The value of primate models for studying human immunodeficiency virus pathogenesis. Levy JA J Med Primatol; 1996 Jun; 25(3):163-74. PubMed ID: 8892037 [TBL] [Abstract][Full Text] [Related]
6. Testing anti-HIV drugs in the FIV model. North TW; LaCasse RA Nat Med; 1995 May; 1(5):410-1. PubMed ID: 7585083 [No Abstract] [Full Text] [Related]
8. Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections. Overbaugh J; Luciw PA; Hoover EA AIDS; 1997; 11 Suppl A():S47-54. PubMed ID: 9451965 [No Abstract] [Full Text] [Related]
9. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus. Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264 [TBL] [Abstract][Full Text] [Related]
11. Feline immunodeficiency virus infection--causative agent of an acquired immunodeficiency syndrome in cats. Hartmann K Eur J Med Res; 1996 Nov; 1(12):547-50. PubMed ID: 9438159 [TBL] [Abstract][Full Text] [Related]
12. [Contribution of animal models to HIV research]. Huot N; Rascle P; Müller-Trutwin M Virologie (Montrouge); 2019 Aug; 23(4):229-240. PubMed ID: 31414660 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of antiretrovirals in animal models of HIV infection. Van Rompay KK Antiviral Res; 2010 Jan; 85(1):159-75. PubMed ID: 19622373 [TBL] [Abstract][Full Text] [Related]
15. Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era. He T; Falwell E; Brocca-Cofano E; Pandrea I Curr Opin Virol; 2017 Aug; 25():66-75. PubMed ID: 28803049 [TBL] [Abstract][Full Text] [Related]
16. Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. Elder JH; Dean GA; Hoover EA; Hoxie JA; Malim MH; Mathes L; Neil JC; North TW; Sparger E; Tompkins MB; Tompkins WA; Yamamoto J; Yuhki N; Pedersen NC; Miller RH AIDS Res Hum Retroviruses; 1998 Jun; 14(9):797-801. PubMed ID: 9643379 [No Abstract] [Full Text] [Related]
18. [Contribution of animal models in the understanding of AIDS encephalopathy]. Boche D; Gray F; Khatissian E; Hurtrel M; Montagnier L; Hurtrel B Arch Anat Cytol Pathol; 1997; 45(2-3):75-85. PubMed ID: 9382613 [TBL] [Abstract][Full Text] [Related]
19. New drug makes host cell machinery unavailable to HIV. Senior K Mol Med Today; 1999 Jun; 5(6):234-5. PubMed ID: 10366815 [No Abstract] [Full Text] [Related]